Key Statistics for CBRX
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (12/2013)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CBRX
- Net Income (M/USD)
Columbia Laboratories, Inc. is an international pharmaceutical company that develops and markets women's health care and endocrinology products. The Company develops products intended to treat infertility, dysmenorrhea, endometriosis, and hormonal deficiencies, primarily utilizing its Bioadhesive Delivery System technology. Columbia markets Striant, and Prochieve 8% and 4%.
More Company Profile & Key Executives for CBRX
|Frank C Condella JrPresident/CEO||Jonathan B Lloyd JonesVP:Finance/CFO/Treasurer/Secy|
|Amy RaskopfManager:Investor Relations|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries